Healthcare / Medical Care FacilitiesNZSE
$0.40
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 11%
FCF escenarios
weak_data · normalized FCF $10.6M · quality 24.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$113M
P/E
10.0x
↓EV/EBITDA
11.2x
↓ROE
10.6%
↑Gross Margin
100.0%
↑Debt/Equity
2.90
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.0%
FCF CAGR
—
FCF margin
8.0%
FCF / Net income
2.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $177.3M · net income $7.0M · FCF $14.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $177.3M | $177.3M | $144.7M | $146.3M | $133.4M |
| Net Income | $7.0M | $7.0M | $-8.5M | $-2.1M | $2.7M |
| EBITDA | $27.1M | $27.1M | $29.2M | $19.5M | $23.4M |
| EPS | 0.03 | 0.03 | -0.03 | -0.01 | 0.01 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 10.9% | 10.9% | 20.1% | 6.0% | 7.2% |
| Net Margin | 4.0% | 4.0% | -5.9% | -1.4% | 2.0% |
| Balance Sheet | |||||
| Debt/Equity | 2.90 | 2.90 | 4.23 | 3.05 | 2.46 |
| Current Ratio | 0.45 | 0.45 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $14.2M | $14.2M | $10.6M | $-54.6M | $-28.6M |
| Returns | |||||
| ROE | 10.6% | 10.6% | -13.2% | -2.9% | 3.8% |
| Valuation | |||||
| P/E | 10.00 | 10.00 | — | — | 34.07 |
| EV/EBITDA | 11.24 | 11.24 | 10.54 | 14.94 | 11.21 |
| P/B | 1.71 | 1.71 | 0.57 | 0.95 | 1.31 |
| Growth & Yield | |||||
| Revenue Growth | 22.5% | 22.5% | -1.1% | 9.7% | — |
| EPS Growth | 187.2% | 187.2% | -292.1% | -167.3% | — |
| Dividend Yield | 6.0% | 6.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
10.9%
EPS terminal req.
$0.04
Spread vs growth
176.3%
5Y implied EPS CAGR
10.6%
EPS terminal req.
$0.04
Spread vs growth
176.7%
10Y implied EPS CAGR
10.3%
EPS terminal req.
$0.07
Spread vs growth
177.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+54.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.03 → 0.03
Residual
+48.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.